Glomangiomyoma is a rare growth that usually forms in the skin or soft tissue and is most often benign, which means it is not cancer. People with glomangiomyoma often notice a small painful lump, tenderness, or sensitivity to pressure, and early symptoms of glomangiomyoma can be easy to mistake for a minor injury. It may help to know that doctors have studied this condition for decades, and many cases are found in adults, although the age at diagnosis can vary. Glomangiomyoma usually does not shorten life expectancy, but the discomfort can last until it is treated. The most common treatment is surgical removal, and this often relieves pain when the growth can be fully removed.
How many people live with Glomangiomyoma?
Global and U.S. prevalence estimates for glomangiomyoma are not consistently reported by a single authoritative source. It is generally described in the medical literature as an exceptionally rare subtype of glomus tumor, so no reliable worldwide or U.S. population count is available.
Overview
GlomangiomyomaSymptoms
Glomangiomyoma often causes a small, slow-growing lump under the skin that can be tender or sharply painful, especially with pressure or cold. Some people notice swelling or a bluish skin color nearby.
Outlook and prognosis
Glomangiomyoma is usually benign and slow-growing. Many people do well after complete removal, with pain and tenderness often easing. Symptoms can return if some tissue remains, so follow-up matters.
Causes and risk factors
Glomangiomyoma usually results from a gene change that often happens by chance and can sometimes run in families. There are no proven lifestyle or environmental causes. Family history may raise risk, and tumor size or location can affect symptoms.
Genetic influences
Genetics can matter in glomangiomyoma, especially when there are multiple lesions or a family history. In some families, changes in the GLMN gene raise the chance of related growths, but many glomangiomyomas happen sporadically.
Diagnosis
Glomangiomyoma is usually diagnosed after an exam and imaging, often ultrasound or MRI. A biopsy or removal sample confirms the diagnosis of glomangiomyoma by showing its typical cells under the microscope. Blood tests do not usually make the diagnosis.
Treatment and drugs
Glomangiomyoma is often treated only if it causes pain, tenderness, or cosmetic concerns. Small, stable spots may just be monitored. For bothersome growths, surgery is most common, while some lesions may be treated with laser or sclerotherapy.
Symptoms
Glomangiomyoma often shows up as a small spot or lump that hurts more than its size would suggest, especially when touched or pressed. Some people notice a blue, red, purple, or skin-colored bump, while others mainly feel pinpoint pain or tenderness. Symptoms vary from person to person and can change over time. Because this tumor is rare, the early symptoms of glomangiomyoma can be mistaken for a bruise, cyst, or another harmless-looking bump.
The most common symptom is a small area of sharp, aching, or throbbing pain. Many people with glomangiomyoma find that the pain feels much stronger than expected for such a tiny lump.
Even light pressure, such as pressing on a fingertip, putting on shoes, or bumping the area against a table, can hurt. The soreness is often very precise, with one spot that feels especially painful.
Cold air, cool water, or holding something chilled can trigger or worsen pain, especially when glomangiomyoma is in a finger or under a nail. The discomfort may improve again after the area warms up.
Some people notice a small bump under the skin that looks blue, purple, red, or close to the surrounding skin color. It may stay the same size for a long time or slowly become easier to see.
How people usually first notice Glomangiomyoma?
Many people first notice glomangiomyoma as a small, slow-growing lump under the skin that may look bluish or skin-colored and can become sharply painful when touched, bumped, or exposed to cold. How glomangiomyoma is first noticed can vary by location, but common early clues are tenderness, a pinpoint area of intense pain, or discomfort that seems stronger than the size of the lump would suggest. Because these tumors are uncommon and often benign, the first signs of glomangiomyoma are sometimes mistaken for a cyst, bruise, or other harmless skin bump until the pain keeps returning or the spot gradually enlarges.
Types of Glomangiomyoma
No distinct types of glomangiomyoma are widely recognized.
Can I slow down the onset of symptoms?
No, for glomangiomyoma, there is no good evidence that lifestyle changes or medicines can meaningfully delay when symptoms start. Research has not shown that diet, exercise, sleep, or supplements prevent these usually noncancerous growths, and while avoiding pressure or cold on the area may sometimes reduce pain after a lump appears, that is not the same as delaying or preventing the condition. There are no standard screening tests or preventive drugs for glomangiomyoma, but having a new painful or growing lump checked early can help you get the right care, and treatment often helps when symptoms become bothersome.
What genetics can tell you about symptoms
For people with glomangiomyoma, genetics usually cannot predict symptoms very well, because most cases are isolated and symptoms are driven more by where the growth is, how large it is, and whether it presses on nearby tissue. In related glomus-type conditions, inherited changes in the GLMN gene can raise the chance of developing multiple lesions, which may mean symptoms start earlier or involve more than one area, but this does not clearly predict exactly which symptoms someone will have or how severe each one will be. In day-to-day life, that means genetics may sometimes help explain why these growths run in a family, while the pain, tenderness, or swelling a person notices still depends mostly on the individual tumor itself.
Causes and risk factors
Most glomangiomyomas happen by chance, and doctors often cannot find one clear cause. In a small number of cases, an inherited change in the GLMN gene can raise the risk of glomus-type tumors. Researchers are still learning how these pieces fit together. Glomangiomyoma is seen more often in adults, and a prior injury in the same area may sometimes play a part. No lifestyle habit has been proven to cause glomangiomyoma, but talk with your doctor if you notice early symptoms of glomangiomyoma or have a family history of similar tumors.
What are the most common causes or risk factors?
For glomangiomyoma, the exact cause is usually not known, and most people develop it by chance rather than because of anything they did. The main known risk factor is a family history of similar growths, because some families inherit a change in a gene called GLMN that can make these growths more likely. There are no well-proven lifestyle or environmental causes, and many living with glomangiomyoma have no clear risk factor at all.
Environmental and biological risk factors
Glomangiomyoma is a very rare growth, and the risk factors for glomangiomyoma are not well defined. Most cases appear to happen sporadically, without a clear outside cause. Doctors often group risks into internal (biological) and external (environmental), but for this condition the best-supported clues are biological and still fairly limited.
Glomangiomyoma is reported most often in adults, especially young to middle-aged adults. Age may play a role, although this tumor can still occur outside those years.
These tumors are more likely to arise in areas that contain glomus tissue, such as under the nails and in the hands or feet. This seems to reflect where the tissue of origin is found in the body, rather than a day-to-day exposure.
Some glomus tumors, especially those under a fingernail, are seen more often in women. For glomangiomyoma itself, the evidence is too limited to call sex a strong or consistent risk factor.
A past injury or repeated irritation to one area has been described in some case reports of glomus-type tumors. This link is not proven, so trauma is considered a possible trigger rather than a well-established risk factor for glomangiomyoma.
Genetic risk factors
For most people with glomangiomyoma, there is no clear inherited reason why the growth appeared. The strongest known genetic link involves changes in the GLMN gene, mainly in families with multiple glomus-type growths rather than one isolated tumor. Carrying a genetic change doesn’t guarantee the condition will appear. Because glomangiomyoma is rare, the full set of genetic risk factors for glomangiomyoma is still not fully mapped out.
GLMN changes: Changes in the GLMN gene are the clearest inherited risk linked to glomus-related growths. They are seen more often in families with several tumors or with glomuvenous malformations, a related condition that can cause small blue-purple skin bumps.
Family history: Having close relatives with glomus tumors or glomuvenous malformations makes an inherited cause more likely. This clue is stronger when several family members are affected or when growths appear across generations.
Inheritance pattern: When GLMN-related risk is present, it usually follows an autosomal dominant pattern, meaning one changed copy of the gene can be enough to pass on the tendency. Even within the same family, the number, size, and location of growths can vary a lot.
Multiple growths: More than one glomus-type growth in the same person can point to a genetic tendency rather than a one-time random event. In that situation, doctors may ask more about family history and sometimes discuss genetic testing.
Isolated cases: A single glomangiomyoma often has no known inherited cause. Many people with glomangiomyoma do not have a family history, and current evidence does not show one common gene change behind most solitary cases.
Lifestyle risk factors
There are no well-established lifestyle habits known to cause glomangiomyoma. In practice, how lifestyle affects glomangiomyoma is more about symptom flares, local irritation, recovery after treatment, and the chance of complications than about the tumor starting in the first place. Because these lesions can be painful and sensitive to pressure or trauma, daily habits can still matter.
Smoking does not cause glomangiomyoma, but it can reduce blood flow and slow healing in tissue around the lesion. This may worsen pain sensitivity and increase recovery problems after biopsy or surgical removal.
Repeated pressure, friction, or minor injury over the affected area can trigger more pain and tenderness from glomangiomyoma. Choosing footwear, clothing, and activities that limit local trauma may reduce symptom flares.
Physical activity is usually healthy, but high-impact or contact exercise can aggravate a painful lesion if it is exposed to pressure or repeated ضرب?.
Risk prevention
For most people, there is no proven way to prevent glomangiomyoma itself. These growths are usually not linked to everyday habits like diet, exercise, or stress, so prevention is mostly about recognizing risk, getting an accurate diagnosis, and lowering the chance of ongoing pain or other problems. In some families, glomangiomyoma or related glomus-type growths can run in relatives, which may change how doctors think about risk. Prevention is about lowering risk, not eliminating it completely.
Some cases of glomangiomyoma may be linked to inherited risk, especially when several relatives have similar painful skin or soft-tissue bumps. Sharing that history with your doctor can help decide whether genetic counseling or closer follow-up makes sense.
There is no routine screening test to stop glomangiomyoma from forming, but early review of a new tender lump can help prevent delays in care. This matters because early symptoms of glomangiomyoma are often mistaken for a cyst, bruise, or another harmless skin bump.
If a glomangiomyoma is already present, repeated pressure or minor injury to the area can make pain more noticeable in daily life. Padding the area, avoiding tight shoes or clothing, and adjusting activities may help reduce flare-ups until it is assessed.
A painful lump under the skin may need imaging or removal to confirm what it is, because glomangiomyoma can look like several other conditions. Getting the right diagnosis early can lower the risk of unnecessary treatments and ongoing symptoms.
Can you prevent Glomangiomyoma?
No, there is no proven way to prevent glomangiomyoma, a rare usually noncancerous growth, because it is most often linked to changes in genes rather than to diet, exercise, or other daily habits. If similar growths run in your family, talking with your doctor or a genetics specialist may help you understand your risk, but it cannot reliably prevent one from developing.
Transmission
Glomangiomyoma is not infectious, so you cannot catch it from someone else in everyday life. It does not spread through touch, kissing, sex, coughing, blood, or shared food and drinks.
For many living with glomangiomyoma, it develops sporadically, which means it appears without being passed from parent to child. Rarely, similar glomus-type growths can run in families, so if several relatives have had them, a genetics specialist can help explain how glomangiomyoma is inherited in that situation.
When to test your genes
Genetic testing is usually worth considering if glomangiomyoma occurs with multiple similar skin lesions, starts in childhood, recurs, or runs in your family, because some cases are linked to changes in the GLMN gene. For a single isolated tumor, testing is often not needed, but it can help guide family counseling when the pattern suggests an inherited condition.
Diagnosis
Glomangiomyoma is usually diagnosed after a painful skin or soft-tissue lump is noticed, often because it hurts with pressure or cold or keeps bothering the same spot. Doctors usually begin with a physical exam and questions about when the lump appeared, how fast it has grown, and whether there is tenderness or color change. Getting a diagnosis is often a turning point toward answers and support. The diagnosis of glomangiomyoma is confirmed by looking closely at the tissue after it is removed or biopsied.
A clinician checks the size, location, color, and tenderness of the lump and asks about symptoms such as pain with touch or temperature changes. This helps narrow down whether the growth behaves like a glomus-type tumor or another common skin or soft-tissue lump.
Ultrasound or MRI may be used to show the exact size of the mass and how deep it extends under the skin. These imaging findings can help with surgical planning and make it easier to tell glomangiomyoma from cysts, blood vessel growths, or other soft-tissue tumors.
If the diagnosis is uncertain, your provider may suggest a biopsy to look closer at the cells under a microscope. In many cases, the whole lump is removed first and then tested, which both treats the problem and confirms what it is.
A pathologist looks for the typical pattern of rounded glomus cells, prominent blood vessels, and areas where the cells take on smooth-muscle features. These clinical features are what separate glomangiomyoma from related tumors such as glomus tumor or glomangioma.
How is Glomangiomyoma diagnosed?
Doctors usually diagnose glomangiomyoma by examining the lump, asking about pain and how it has changed over time, and using scans such as an ultrasound or MRI to see how deep it is and what it looks like. Because it can look like other kinds of growths, the diagnosis is usually confirmed by removing all or part of it and checking the tissue under a microscope. Genetic testing is not usually needed for one isolated growth, but it may be considered if someone has several similar growths or a strong family history.
Stages of Glomangiomyoma
Glomangiomyoma does not have defined progression stages. This is because it is usually a localized growth rather than an illness that moves through predictable steps over time. Doctors usually start with a conversation about when the lump or pain began, whether it is changing, and whether touch, pressure, or temperature seem to trigger symptoms, since the early symptoms of glomangiomyoma can be easy to mistake for other causes of a tender skin nodule. Diagnosis is usually confirmed with an exam, imaging in some cases, and most often by looking at the tissue under a microscope after removal or biopsy.
Outlook and prognosis
The outlook for people with glomangiomyoma is generally excellent because these tumors are usually benign, slow growing, and effectively treated with complete surgical removal. Most patients experience substantial relief of pain or tenderness after excision, and long-term outcomes are very good. Recurrence can occur, especially if the lesion is not fully removed or if there are multiple lesions, but repeat treatment is often successful. Malignant transformation is exceptionally rare, and when it does happen it is associated with atypical features such as large size, deep location, or aggressive growth. Mortality from a typical glomangiomyoma is exceedingly uncommon, with deaths reported only in the very rare malignant cases. Ongoing follow-up may be advised when symptoms return, the tumor has unusual pathology, or there is concern for inherited glomus tumor syndromes.
Long-term effects
For many people, glomangiomyoma remains a localized growth, but it can keep affecting daily comfort if it presses on nearby tissue. The long-term picture is often shaped by where the tumor sits, such as under a nail, in a finger or toe, or deeper in soft tissue. Many living with glomangiomyoma do well after treatment, though some may have ongoing pain or a return of the growth over time. When people search for the long-term effects of glomangiomyoma, the main concerns are usually pain, sensitivity, function, and recurrence rather than spread throughout the body.
Pain may continue for months or years if glomangiomyoma is not fully removed or if the area stays irritated. Some may find that even light touch can trigger a sharp, localized ache.
Many people with glomangiomyoma notice that cold air, cool water, or air conditioning brings on marked discomfort. This can make simple tasks like washing hands or walking outside in winter harder than expected.
When the tumor affects a finger, toe, hand, or foot, long-term discomfort can reduce grip, walking comfort, or fine movements. Over time, daily routines may shift because small actions like buttoning clothes or typing become painful.
A glomangiomyoma under or near a nail can leave lasting nail deformity, tenderness, or a visible bump. In some cases, pressure on the nail bed changes how the nail grows back.
How is it to live with Glomangiomyoma?
Living with glomangiomyoma often means living with a small tumor that can cause very outsized symptoms, especially sharp, localized pain and tenderness, sometimes made worse by touch, pressure, or cold. For many people, daily life is affected in practical ways rather than dramatic ones: using a hand, wearing certain shoes, sitting comfortably, exercising, or sleeping on the area may become difficult, depending on where the growth is located. Because the condition is usually benign, the biggest burden is often ongoing discomfort and the uncertainty of not knowing why such a small spot hurts so much, and people around you may need to understand that the pain is real even when there is little to see from the outside. Once it is identified and treated, often with surgical removal, many people find that day-to-day life becomes much easier.
Treatment and drugs
Treatment for glomangiomyoma depends mostly on where the growth is, how large it is, and whether it is causing pain or tenderness in daily life, such as when a lesion hurts with pressure, cold, or simple activities like walking or using your hands. The main treatment for glomangiomyoma is usually surgery to remove the growth, which can often relieve symptoms and may be curative when the whole lesion can be taken out. If a glomangiomyoma is small and not bothering you, doctors may suggest monitoring it instead of treating it right away. Supportive care can make a real difference in how you feel day to day, and this may include pain-relieving medicine and avoiding triggers that make the area more sensitive. Because early symptoms of glomangiomyoma can overlap with other skin or soft-tissue problems, treatment is often planned with a specialist to confirm the diagnosis and choose the safest option.
Can you cure Glomangiomyoma?
Glomangiomyoma is usually a noncancerous growth, and many people can be cured if the whole lump is removed with surgery. There is not a medicine that cures it, but treatment can take away pain and other symptoms, and if any part of the growth is left behind, it may come back.
Non-drug treatment
Living with glomangiomyoma often means dealing with a small lump that can be tender with pressure, bumped in daily life, or sensitive to temperature changes. Because these growths are usually benign, non-drug care focuses on confirming the diagnosis, easing day-to-day discomfort, and deciding whether a procedure is needed. For many, treatment begins not at the pharmacy, but with careful monitoring and planning with a surgeon or skin specialist. The right approach depends on where the growth is, how painful it is, and whether there is one lesion or several.
Small glomangiomyomas that are not painful or changing may simply be monitored over time. Follow-up visits help check for growth, new symptoms, or signs that treatment for glomangiomyoma should be reconsidered.
Surgery is the main non-drug treatment when a glomangiomyoma causes pain, gets larger, or interferes with daily activities. Removing the lesion often relieves symptoms and also lets the tissue be examined to confirm the diagnosis.
Ultrasound or MRI can help show the exact size and depth of a glomangiomyoma before treatment. This is especially useful when the lump is hard to feel clearly or sits near nerves, blood vessels, or a nail.
Cushioning the area, avoiding repeated bumps, and choosing footwear or clothing that does not press on the lesion can lessen discomfort. Some may find symptoms flare when the spot is knocked during walking, exercise, or chores.
Your genes may have an impact on how drugs work for you
For glomangiomyoma, treatment is usually based on removing the growth rather than using long-term medicine, so there is no well-established genetic test that helps predict how medicines will work for this condition. Some people have an inherited tendency to develop these growths, but that usually helps explain why they occur, not which pain medicine, numbing medicine, or other treatment will work best. In day-to-day care, medicine response is more often shaped by things like age, other health problems, and the type of procedure than by genes linked to glomangiomyoma itself.
Pharmacological treatments
For most people with glomangiomyoma, medicine is not the main treatment because these tumors are usually managed with a procedure to remove them. Medication can feel like a big step, but for glomangiomyoma it is usually used to ease symptoms such as pain rather than to make the tumor go away. Because this tumor is rare, there is no standard drug that is approved specifically for it. The choice of medicine depends on where the tumor is, how painful it is, and whether surgery is planned.
Acetaminophen and nonsteroidal anti-inflammatory drugs such as ibuprofen or naproxen may help reduce the tenderness and throbbing that some people with glomangiomyoma feel. These are usually short-term options for symptom relief, not a cure for the tumor.
Numbing medicines such as lidocaine may be used during an exam, biopsy, or minor procedure to control pain in the area. They can help briefly, but they are not considered ongoing treatment for glomangiomyoma.
If pain is severe and simple pain relievers are not enough, a doctor may occasionally prescribe a stronger short-term pain medicine. This is uncommon and is usually reserved for special situations, such as while waiting for definitive treatment or recovering after a procedure.
In rare, complex cases that overlap with other vascular growth disorders, specialists may consider medicines such as sirolimus to help with symptoms or lesion burden. This is not routine treatment for glomangiomyoma, and evidence is limited, so care is usually guided by an expert team.
Genetic influences
Most glomangiomyoma cases are thought to happen sporadically, which means they usually are not caused by a gene change inherited through a family. It’s natural to ask whether family history plays a role. A related group of glomus-type growths, especially when there are many lesions or several relatives are affected, can be linked to changes in the glomulin gene, also called GLMN, and this tendency can be passed from parent to child. That does not mean every glomangiomyoma has a hereditary cause, and a single glomangiomyoma with no family pattern is often not inherited. If you are wondering whether glomangiomyoma runs in families, doctors may look at how many tumors there are, when they started, and whether close relatives have had similar growths. When that history suggests a genetic link, genetic counseling and sometimes testing may help clarify the risk for other family members.
Is Glomangiomyoma genetic?
Genetics can matter in glomangiomyoma, especially when there are multiple lesions or a family history. In some families, changes in the GLMN gene raise the chance of related growths, but many glomangiomyomas happen sporadically.
Having a genetic risk is not necessarily a diagnosis
Changes in genes are a usual part of being human and are common throughout the general population. Most of these changes do not directly affect health and simply reflect normal human diversity. For many genes, having a change associated with a condition points to a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some cases, though, a single well-characterized change in a specific gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many people with glomangiomyoma, genetics matters more for confirming what the growth is and whether similar growths might run in a family than for choosing a specific drug. In practice, treatment for glomangiomyoma is often focused on removing the lump or easing symptoms such as pain, rather than using long-term medicines targeted to a gene change. Not every difference in response is genetic, but there are no widely used pharmacogenetic tests that reliably tell doctors which medication will work best for glomangiomyoma. If medicines are used, they are usually chosen based on where the tumor is, how severe symptoms are, and a person’s overall health, not on a known glomangiomyoma genetic result. When glomangiomyoma appears along with multiple similar lesions or a family pattern, genetic testing may help with diagnosis and family counseling, but it does not usually change day-to-day drug treatment.
Interactions with other conditions
For many living with glomangiomyoma, the main issue is usually the lump itself and the pain or tenderness it can cause, rather than it directly leading to other diseases. Glomangiomyoma can, however, overlap in symptoms with other soft tissue or blood-vessel growths, so it may at first be mistaken for things like a cyst, a hemangioma, or another painful skin or under-the-skin tumor. In some families, multiple glomus-type growths are linked to an inherited tendency, so doctors may also think about related conditions such as glomuvenous malformations when several lesions are present. Interactions can look very different from person to person. If glomangiomyoma sits near a nerve, joint, or under a nail, another problem in the same area, such as arthritis or nerve irritation, can make the pain feel worse and make early symptoms of glomangiomyoma harder to sort out.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Glomangiomyoma?
A small, painful lump like a glomangiomyoma can also be caused by other growths, especially other glomus tumors, blood vessel growths, nerve-related lumps, or a cyst. If it is under a nail or in a fingertip, doctors may also think about a bruise, an infection, or, less often, a serious skin cancer called melanoma, because these can also cause pain, color change, and tenderness to touch.
History
People living with glomangiomyoma often spend years thinking they simply have an unusual lump under the skin, especially if it grows slowly and does not cause much trouble at first. In some, the area becomes tender with pressure, temperature changes, or everyday bumps, which is often what finally brings it to medical attention. Although the name sounds modern, these growths are part of a longer medical story about small tumors linked to the body’s temperature-control structures in the skin.
In recent decades, awareness has grown as doctors have become better at telling glomangiomyoma apart from other soft tissue lumps. Early descriptions of related glomus tumors appeared in pathology reports in the late 19th and early 20th centuries, when physicians began matching symptoms such as pain and sensitivity with what they saw under the microscope. Over time, specialists recognized that not all of these tumors looked the same, and glomangiomyoma came to be understood as one of the less common forms, showing features of both blood vessel tissue and smooth muscle cells.
This history matters because glomangiomyoma was not always easy to classify. For many years, similar growths could be grouped together or mistaken for other benign tumors, especially before modern imaging and more detailed laboratory testing were widely available. As medical science evolved, pathologists developed clearer criteria, which helped improve diagnosis and made it easier to explain why some people had a single lesion while others had more than one.
Researchers later identified that some glomus-related tumors can have a genetic basis, which added another layer to how these conditions are understood, though not every case follows the same pattern. Today, the history of glomangiomyoma is less about a dramatic discovery and more about steady progress: better naming, better recognition, and fewer missed diagnoses. That can make a real difference for people trying to understand unexplained skin or soft tissue nodules and the early symptoms of glomangiomyoma.